Och-Ziff Capital Management Group LLC (OZM) Discloses Poor Returns for August But Still Attracts Big Money

Daniel S. Och’s Och-Ziff Capital Management Group LLC (NYSE:OZM) (a.k.a. OZ Management) disclosed on Wednesday –with the SEC- its Estimated Unaudited Returns* and Estimated Unaudited Assets Under Management for August 2014. Its flagship fund, the OZ Master Fund, returned 0.49% in August**, and 2.57% between January 1 and August 31, 2014, inclusive. In addition, its OZ Europe Master Fund and OZ Asia Master Fund both posted negative returns for both August and the first eight months of the year.

The OZ Europe Master Fund lost 0.04% in August and 1.47% year-to-date, while the OZ Asia Master Fund fell 0.03% in August, and 4.25% year-to-date. According to this information, all of Och-Ziff Capital Management Group LLC (NYSE:OZM)’s main funds have underperformed the S&P 500 index, which has inched 8.19% year-to-date, and 3.77% in August alone. According to the fund’s public disclosures, the gains obtained from credit-related investments were surpassed by the losses that European and Asian stocks registered.

Och-Ziff Capital Management

Och-Ziff Capital Management Group LLC (NYSE:OZM) also declared estimated unaudited assets under management of $46.1 billion, as of September 1, 2014. This implies a net increase of approximately $400 million from the $45.7 billion acknowledged as of August 1, 2014.

The hedge fund’s performance for July had been somewhat opposite: the OZ Master Fund had lost 0.12%, and the OZ Europe Master Fund and OZ Asia Master Fund had inched, 0.27% and 2.41%, respectively.

The funds’ weak performance has certainly been reflected on Och-Ziff Capital Management Group LLC (NYSE:OZM)’s stock, which lost 14.8% year-to-date, and 9.04% in August alone. However, another factor has also impacted on this steep fall. The fund has been object of plenty of bad press regarding some business dealings in Africa, which could include bribery and political corruption cases in Libya, the Democratic Republic of Congo, and Zimbabwe.

Despite this downtrend, the fund continues to attract big money. Since the beginning of the year, OZ Management has achieved to increase its assets under management by approximately $5.9 billion. Amongst the best-known investors in on Och-Ziff Capital Management Group LLC (NYSE:OZM), I would like to highlight Chuck Royce’s Royce & Associates, which last disclosed a 48% increase in its stake, and now owns 181,400 shares of the company. For his part, Jim Simons’ Renaissance Technologies last trimmed its exposure to the company by 57% and now owns 715,100 shares – or almost $10 million in stock.

* This information is being provided for investors in the company’s main master funds, and “is not necessarily indicative of the Company’s anticipated financial results” (SEC).

** Monthly performance data are based on the management’s estimates, and may change upon completion of the company’s month-end valuation procedures.

“Net return represents a composite of the average return of the feeder funds that comprise each of the Company’s most significant master funds. Net return is presented on a total return basis, net of all fees and expenses (except incentive income on unrealized gains attributable to investments that the Company, as investment manager, determines lack a readily ascertainable fair value, are illiquid or otherwise should be held until the resolution of a special event or circumstance (“Special Investments”) that could reduce returns on such Special Investments at the time of realization) and includes the reinvestment of all dividends and other income. Performance includes realized and unrealized gains and losses attributable to Special Investments and initial public offering investments that are not allocated to all investors in the feeder funds. Investors that were not allocated Special Investments and/or initial public offering investments may experience materially different returns” (SEC).

Disclosure: Javier Hasse holds no positions in any stocks or funds mentioned.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!